Search results
May 28, 2024 · Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
May 13, 2024 · Access financial information, investor relations library, analyst coverage and more. Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company.
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd ...
Of the many R&D programs Astellas has underway, 22 are related to our Rx (prescription drug) business. We also advance Rx+ ® business, which aims to contribute to patients across the whole patient journey (overall medical care, including diagnostic, preventive, therapeutic and prognostic care).
May 12, 2023 · Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause. VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause. TOKYO, May 12, 2023 / PRNewswire / -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura ...
Official website for Astellas Pharma EMEA. Learn about Corporate Information, Research & Development and Corporate Social Responsibility (CSR).
Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products focus on therapeutic fields that include transplantation ...
